Are European Stocks Peaking? SocGen,Citi Turn Bearish on Q4, U.S. Regional Bank Crisis Adds New Risk

TradingKey
Updated
Mitrade
coverImg
Source: DepositPhotos

TradingKey - A series of bad loan incidents in the U.S. are catalyzing a credit crisis in the banking sector, and these concerns are now spreading to Europe’s top-performing bank stocks this year. The worry comes at a time when institutions like Citi and Société Générale are turning cautious on European equities for Q4 — raising fears that credit issues could intensify pressure on European markets.

As of writing (October 17), the Stoxx 600 Banks Index plunged 2.70%, with major banks including Deutsche Bank, Société Générale, and Barclays all falling over 4%. The day before, the U.S. regional bank index (KRE) dropped over 6% after Zions Bancorp and Western Alliance disclosed significant loan fraud losses.

stoxx-europe-600-banks-index

Source: MarketWatch

Panmure Liberum said the market’s initial negative reaction reflects growing fears that problems facing U.S. banks could spill over into Europe — similar to the regional banking crisis of 2023. Given that valuations were already somewhat stretched, the sell-off in banks is understandable.

The banking sector has been the best-performing area in European equity markets this year, with the relevant index up over 40% year-to-date. With European stocks near record highs, more analysts are warning that further gains may be hard to achieve this quarter amid headwinds such as China-U.S. trade tensions.

According to a recent Bloomberg survey of strategists, the average year-end target for the Stoxx 600 is 560, about 2% below Thursday’s closing level of 571.66. So far in 2025, the index has risen approximately 41%, outperforming the U.S. S&P 500’s 13% gain.

Citi noted that fresh developments from China, combined with earnings season, will drive volatility in European markets — but it remains optimistic about mid-2026 outlooks, emphasizing that sustained earnings growth remains key to further stock gains.

Société Générale believes that due to political and geopolitical uncertainty, coupled with a lack of positive earnings momentum, markets will face pressure toward year-end. The firm set its 2025 Stoxx 600 target at just 530 points.

However, similar to Citi, SocGen maintains a positive view on European stocks in 2026, supported by expected fiscal stimulus and continued accommodative monetary policy.

* The content presented above, whether from a third party or not, is considered as general advice only.  This article should not be construed as containing investment advice, investment recommendations, an offer of or solicitation for any transactions in financial instruments.

goTop
quote
Do you find this article useful?
Related Articles
placeholder
Netflix Q3 Earnings Preview: Double Growth in Revenue and Profit Expected Amid Wall Street's Universal OptimismStreaming giant Netflix is set to release its Q3 2025 financial results after U.S. market close on Tuesday, October 21, with the current market sentiment largely optimistic.
Author  TradingKey
9 hours ago
Streaming giant Netflix is set to release its Q3 2025 financial results after U.S. market close on Tuesday, October 21, with the current market sentiment largely optimistic.
placeholder
Dow Jones futures rise due to easing US-China trade tensions, Fed rate cut betsDow Jones futures advance 0.37% to rise near 46,550 during European hours, ahead of the opening of the United States (US) regular session on Monday.
Author  FXStreet
10 hours ago
Dow Jones futures advance 0.37% to rise near 46,550 during European hours, ahead of the opening of the United States (US) regular session on Monday.
placeholder
Japan and Korea Lead Asian Stock Surge — Nikkei 225 Breaks 49,000, KOSPI Tops 3,800Asian equities rallied broadly on Monday, October 20, with Japan and South Korea setting fresh record highs.
Author  TradingKey
11 hours ago
Asian equities rallied broadly on Monday, October 20, with Japan and South Korea setting fresh record highs.
placeholder
Lilly, Novo Nordisk Shares Plummet as Trump Announces Price Cut to OzempicOn Thursday, shares of Eli Lilly and Novo Nordisk fell sharply in after-hours trading after President Donald Trump announced a significant price reduction for the diabetes drug Ozempic.
Author  TradingKey
Oct 17, Fri
On Thursday, shares of Eli Lilly and Novo Nordisk fell sharply in after-hours trading after President Donald Trump announced a significant price reduction for the diabetes drug Ozempic.
placeholder
Nio faces Singapore lawsuit for alleged revenue manipulation as shares plungeNio is being sued by Singapore’s GIC for allegedly inflating over $600 million in revenue through a hidden affiliate.
Author  Cryptopolitan
Oct 16, Thu
Nio is being sued by Singapore’s GIC for allegedly inflating over $600 million in revenue through a hidden affiliate.